22 December 2020 : Original article
Circulating NKG2A–NKG2D+ CD56dimCD16+ Natural Killer (NK) Cells as Mediators of Functional Immunosurveillance in Kidney Transplant Recipients
Li Zhu12ABCDEF, Hristos Karakizlis3B, Rolf Weimer3B, Christian Morath4B, Naruemol Ekpoom2B, Eman H. Ibrahim2BE, Gerhard Opelz2ADEF, Volker Daniel2ABCDEF*DOI: 10.12659/AOT.925162
Ann Transplant 2020; 25:e925162
Table 1 Demographic data of patients the late post-transplant period.
| Late post-Tx (n=35) | |
|---|---|
| 52 (29–69) | |
| 1168 (95–3786) | |
| Female | 14 (40%) |
| Male | 21 (60%) |
| Living | 24 (69%) |
| Deceased | 11 (31%) |
| First | 33 (94%) |
| Second | 2 (6%) |
| <3 hours | 24 (69%) |
| >3 hours | 9 (31%) |
| <35 ml/min | 2 (6%) |
| 35–50 ml/min | 8 (23%) |
| >50 ml/min | 25 (71%) |
| <2 mg/dl | 31 (89%) |
| >2 mg/dl | 4 (11%) |
| 12 (34%) | |
| 15 (43%) | |
| 17 (49%) | |
| Chronic glomerulonephritis | 3 (9%) |
| Diabetes | 3 (9%) |
| Hypertension/ischemic | 2 (6%) |
| Nephrosclerosis | 2 (6%) |
| Polycystic | 9 (26%) |
| IgA nephropathy | 6 (17%) |
| Others | 10 (29%) |
| Ciclosporine+steroids+MMF | 7 (20%) |
| Tacrolimus+steroids+MMF | 10 (29%) |
| Tacrolimus+MMF | 14 (40%) |
| Steroids+MMF+everolimus | 2 (6%) |
| Tacrolimus+MMF+everolimus | 1 (3%) |
| Tacrolimus+steroids+MMF+ everolimus | 1 (3%) |
| Late post-Tx – recipients late post-transplant; GFR – glomerular filtration rate; MMF – mycophenolate mofetil. | |